These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27154140)

  • 1. The European Medicines Agency is still too close to industry.
    Garattini S
    BMJ; 2016 May; 353():i2412. PubMed ID: 27154140
    [No Abstract]   [Full Text] [Related]  

  • 2. The innovative medicines initiative: a European response to the innovation challenge.
    Goldman M
    Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Increased commercial financing of national Medical Product Agencies within the EU].
    Ramel B
    Lakartidningen; 2003 Jan; 100(5):338-9. PubMed ID: 12607381
    [No Abstract]   [Full Text] [Related]  

  • 4. [The Medical Product Agency's work and economics--a comment].
    Ahlqvist Rastad J; Salmonson T
    Lakartidningen; 2003 Jan; 100(5):345. PubMed ID: 12607382
    [No Abstract]   [Full Text] [Related]  

  • 5. European Medicines Agency is attacked over proposal to allow technology assessment bodies to sell advice to drug industry.
    Wise J
    BMJ; 2014 Jul; 349():g4674. PubMed ID: 25033980
    [No Abstract]   [Full Text] [Related]  

  • 6. Ahead of its time? Reflecting on New Zealand's Pharmac following its 20th anniversary.
    Gauld R
    Pharmacoeconomics; 2014 Oct; 32(10):937-42. PubMed ID: 24906479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Euro MPs refuse to approve medicines agency's accounts until they tighten rules on conflicts of interest.
    Watson R
    BMJ; 2012 May; 344():e3495. PubMed ID: 22597355
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicines agencies too often under the influence of drug companies.
    Prescrire Int; 2011 Apr; 20(115):108. PubMed ID: 21648219
    [No Abstract]   [Full Text] [Related]  

  • 9. Statisticians in European regulatory agencies.
    Skovlund E
    Pharm Stat; 2009; 8(4):259-63. PubMed ID: 19301357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European Medicines Agency: a public health European agency?
    Mahalatchimy A; Rial-Sebbag E; De Grove-Valdeyron N; Tournay V; Cambon-Thomsen A; Duguet AM; Taboulet F
    Med Law; 2012 Mar; 31(1):25-42. PubMed ID: 22908736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Industry Perspective on the 2017 EMA Guideline on First-in-Human and Early Clinical Trials.
    DeGeorge J; Robertson S; Butler L; Derzi M; Stoch SA; Diaz D; Hartke J; Guzzie-Peck P; Mortimer-Cassen E; Bogdanffy M; Will Y; Greene N
    Clin Pharmacol Ther; 2018 Apr; 103(4):566-569. PubMed ID: 29285748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Brazilian pharmaceutical market and the North American war effort].
    Quintaneiro T
    Estud Hist; 2002; (29):141-64. PubMed ID: 18030707
    [No Abstract]   [Full Text] [Related]  

  • 13. Why the drug development pipeline is not delivering better medicines.
    Naci H; Carter AW; Mossialos E
    BMJ; 2015 Oct; 351():h5542. PubMed ID: 26496934
    [No Abstract]   [Full Text] [Related]  

  • 14. On regulating regulation.
    Lunde I; Dukes MN
    Eur J Clin Pharmacol; 1981 Jan; 19(1):1-2. PubMed ID: 7461019
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicines to remain with European Commission health directorate.
    Watson R
    BMJ; 2014 Oct; 349():g6514. PubMed ID: 25355097
    [No Abstract]   [Full Text] [Related]  

  • 16. European Medicines Agency policies for clinical trials leave women unprotected.
    Ruiz Cantero MT; Angeles Pardo M
    J Epidemiol Community Health; 2006 Nov; 60(11):911-3. PubMed ID: 17053276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Medicines Agency pledges to publish clinical reports.
    Watson R
    BMJ; 2014 Oct; 349():g6086. PubMed ID: 25294699
    [No Abstract]   [Full Text] [Related]  

  • 18. Germany sets up new agency to oversee production of medicinal cannabis.
    Stafford N
    BMJ; 2017 Feb; 356():j706. PubMed ID: 28179227
    [No Abstract]   [Full Text] [Related]  

  • 19. European medicines agency: riddled with conflicts of interest.
    Prescrire Int; 2012 Nov; 21(132):278. PubMed ID: 23210268
    [No Abstract]   [Full Text] [Related]  

  • 20. Europe's sweeping chemical law puts medicines in peril.
    Keim B
    Nat Med; 2007 Jan; 13(1):4. PubMed ID: 17297677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.